NASDAQ:QTNT - Nasdaq - JE00BNNSZY03 - Common Stock - Currency: USD
0.38
+0.01 (+2.73%)
The current stock price of QTNT is 0.38 USD. In the past month the price decreased by -52.38%. In the past year, price decreased by -99.63%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ALC | ALCON INC | 29.9 | 45.13B | ||
COO | COOPER COS INC/THE | 23.91 | 17.66B | ||
ALGN | ALIGN TECHNOLOGY INC | 20.39 | 14.22B | ||
SOLV | SOLVENTUM CORP | 17.55 | 12.61B | ||
MMSI | MERIT MEDICAL SYSTEMS INC | 30.7 | 6.01B | ||
BLCO | BAUSCH + LOMB CORP | 25.4 | 5.55B | ||
LNTH | LANTHEUS HOLDINGS INC | 11.27 | 5.44B | ||
ICUI | ICU MEDICAL INC | 27.69 | 3.85B | ||
XRAY | DENTSPLY SIRONA INC | 10.14 | 3.73B | ||
HAE | HAEMONETICS CORP/MASS | 14.9 | 3.17B | ||
NEOG | NEOGEN CORP | 25.1 | 2.18B | ||
UFPT | UFP TECHNOLOGIES INC | 36.31 | 1.95B |
Quotient Ltd is a CH-based company operating in Health Care Equipment & Supplies industry. Quotient Limited is a Switzerland-based diagnostics company. The firm focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. The company is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. The company is engaged in developing MosaiQ, which is its technology platform. The firm develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Additionally The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).
QUOTIENT LTD
B1, Business Park Terre Bonne, Route de Crassier 13, Eysins
VAUD 1262 CH
CEO: Manuel O. Mendez
Employees: 450
Company Website: http://www.quotientbd.com/
Phone: 41227169800.0
The current stock price of QTNT is 0.38 USD. The price increased by 2.73% in the last trading session.
The exchange symbol of QUOTIENT LTD is QTNT and it is listed on the Nasdaq exchange.
QTNT stock is listed on the Nasdaq exchange.
7 analysts have analysed QTNT and the average price target is 61.2 USD. This implies a price increase of 16005.26% is expected in the next year compared to the current price of 0.38. Check the QUOTIENT LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
QUOTIENT LTD (QTNT) has a market capitalization of 1.29M USD. This makes QTNT a Nano Cap stock.
QUOTIENT LTD (QTNT) currently has 450 employees.
The Revenue of QUOTIENT LTD (QTNT) is expected to grow by 6.8% in the next year. Check the estimates tab for more information on the QTNT EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
QTNT does not pay a dividend.
QUOTIENT LTD (QTNT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-53.21).
ChartMill assigns a fundamental rating of 2 / 10 to QTNT. QTNT has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months QTNT reported a non-GAAP Earnings per Share(EPS) of -53.21. The EPS decreased by -11.79% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 86% to QTNT. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 44.75% and a revenue growth 6.8% for QTNT